Development of Oncolytic Reovirus for Cancer Therapy

Journals Menu

Follow SCIRP

	+1 323-425-8868
	customer@scirp.org
	+86 18163351462(WhatsApp)
	1655362766

	Paper Publishing WeChat

Journal of Cancer Therapy

ISSN Print: 2151-1934
ISSN Online: 2151-1942
www.scirp.org/journal/jct
E-mail: jct@scirp.org

Citations

Journals Menu

"Development of Oncolytic Reovirus for Cancer Therapy"
written by Ergin Sahin, Michael E. Egger, Kelly M. McMasters, Heshan Sam Zhou,
published by Journal of Cancer Therapy, Vol.4 No.6, 2013

has been cited by the following article(s):

Google Scholar
CrossRef

[1]	Oncolytic viruses against cancer, promising or delusion?
	Medical Oncology, 2023

[2]	Low-Intensity Ultrasound as a Novel Strategy to Improve the Cytotoxic Effect of Oncolytic Reovirus on Colorectal Cancer Model Cells
	Dizaji… - Intervirology, 2022

[3]	Oncolytic bacterial and viral therapies as cancer prevention and treatment options: a comprehensive review
	Iranian Red Crescent Medical …, 2022

[4]	Oncolytic Viruses as Immunotherapeutic Agents
	2021

[5]	Oncolytic Viruses in Combination Therapeutic Approaches with Epigenetic Modulators: Past, Present, and Future Perspectives. Cancers (Basel). 2021; 13 (11) …
	2021

[6]	Natural killer T cell immunotherapy combined with oncolytic vesicular stomatitis virus or reovirus treatments differentially increases survival in mouse models …
	2021

[7]	Mesenchymal stem cells support delivery and boost the efficacy of oncolytic reoviruses in TC‐1 tumor cells
	2021

[8]	Oncolytic Viruses in Combination Therapeutic Approaches with Epigenetic Modulators: Past, Present, and Future Perspectives
	2021

[9]	Kinetics of Oncolytic Reovirus T3D Replication and Growth Pattern in Mesenchymal Stem Cells.
	2020

[10]	Kinetics of Oncolytic Reovirus T3D Replication and Growth Pattern in Mesenchymal Stem Cells
	2020

[11]	Mechanism of dsRNA virus replication: cloning, production and structural characterization of N-terminal domain of sigmaNS
	2019

[12]	Piscine orthoreovirus: Distribution, characterization and experimental infections in salmonids
	2019

[13]	DEVELOPING NATURAL KILLER T CELL BASED TOOLS AND STRATEGIES FOR TARGETING BREAST CANCER
	2019

[14]	Purification of Human Reovirus in Monolayer of L-929 Cells
	2019

[15]	Molecular characterization of Human Rotavirus Strains circulating among Children less than 5 years attended with Diarrhea to Mohammed Alamin Hamid …
	2017

[16]	Molecular characterization of Human Rotavirus Strains circulating among Children less than 5 years attended with Diarrhea to Mohammed Alamin Hamid Pediatric …
	2017

[17]	Effects of fat soluble vitamins on viral infection and antiviral responses in Atlantic salmon (Salmo salar L.) erythrocytes
	2017

[18]	WJM
	2016

[19]	Clinical development of reovirus for cancer therapy: An oncolytic virus with immune-mediated antitumor activity
	World journal of Methodology, 2016

[20]	Glycan Engagement Dictates Hydrocephalus Induction by Serotype 1 Reovirus
	mBio, 2015

[21]	Cancer immunology
	2015

[22]	The sweet spot: defining virus–sialic acid interactions
	Nature Reviews Microbiology, 2014

[23]	The Molecular Basis of Serotype 1 Reovirus Glycan Interactions and the Function of Glycan-Binding in Pathogenesis
	2014

[24]	Activated Ras signaling pathways and reovirus oncolysis: an update on the mechanism of preferential reovirus replication in cancer cells
	Frontiers in oncology, 2014

[25]	The sweet spot: defining virus-sialic acid interactions
	Nature Reviews Microbiology, 2014

[26]	The effects of oncolytic reovirus in canine lymphoma cell lines
	Veterinary and comparative oncology, 2014

[1]	Oncolytic viruses against cancer, promising or delusion? Medical Oncology, 2023 DOI:10.1007/s12032-023-02106-6

[2]	Low-Intensity Ultrasound as a Novel Strategy to Improve the Cytotoxic Effect of Oncolytic Reovirus on Colorectal Cancer Model Cells Intervirology, 2022 DOI:10.1159/000519492

[3]	Cancer Immunology 2021 DOI:10.1007/978-3-030-50287-4_27

[4]	Oncolytic Viruses in Combination Therapeutic Approaches with Epigenetic Modulators: Past, Present, and Future Perspectives Cancers, 2021 DOI:10.3390/cancers13112761

[5]	Cancer Immunology 2021 DOI:10.1007/978-3-030-50287-4_27

[6]	Natural killer T cell immunotherapy combined with oncolytic vesicular stomatitis virus or reovirus treatments differentially increases survival in mouse models of ovarian and breast cancer metastasis Journal for ImmunoTherapy of Cancer, 2021 DOI:10.1136/jitc-2020-002096

[7]	Oncolytic Viruses in Combination Therapeutic Approaches with Epigenetic Modulators: Past, Present, and Future Perspectives Cancers, 2021 DOI:10.3390/cancers13112761

[8]	Mesenchymal stem cells support delivery and boost the efficacy of oncolytic reoviruses in TC‐1 tumor cells Journal of Cellular Biochemistry, 2021 DOI:10.1002/jcb.29955

[9]	The effects of oncolytic reovirus in canine lymphoma cell lines Veterinary and Comparative Oncology, 2016 DOI:10.1111/vco.12124

[10]	Clinical development of reovirus for cancer therapy: An oncolytic virus with immune-mediated antitumor activity World Journal of Methodology, 2016 DOI:10.5662/wjm.v6.i1.25

[11]	The effects of oncolytic reovirus in canine lymphoma cell lines Veterinary and Comparative Oncology, 2016 DOI:10.1111/vco.12124

[12]	Glycan Engagement Dictates Hydrocephalus Induction by Serotype 1 Reovirus mBio, 2015 DOI:10.1128/mBio.02356-14

[13]	The sweet spot: defining virus–sialic acid interactions Nature Reviews Microbiology, 2014 DOI:10.1038/nrmicro3346

[14]	Activated Ras Signaling Pathways and Reovirus Oncolysis: An Update on the Mechanism of Preferential Reovirus Replication in Cancer Cells Frontiers in Oncology, 2014 DOI:10.3389/fonc.2014.00167

Follow SCIRP

	+1 323-425-8868
	customer@scirp.org
	+86 18163351462(WhatsApp)
	1655362766

	Paper Publishing WeChat

Journal of Cancer Therapy

Journal of Cancer Therapy

Journals Menu

Home

About SCIRP

Service

Policies